What is ReCode Therapeutics worth?
$700.0Mlast known valuation
ReCode Therapeutics last raised $29.4M in its Debt (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 24 names
- ·Watchlist + deal alerts for ReCode Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Debt | $29.4M | ▮ | ▮ |
| Oct 2021 | Later Stage VC | $259.8M | ▮ | ▮ |
| Mar 2020 | Early Stage VC | $27.5M | ▮ | ▮ |
How ReCode Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For ReCode Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is ReCode Therapeutics worth?
- ReCode Therapeutics's last known valuation is $700.0M.
- How much has ReCode Therapeutics raised?
- ReCode Therapeutics has raised $388.0M in total funding across 3 recorded rounds.
- When did ReCode Therapeutics last raise?
- ReCode Therapeutics last raised in Sep 2025 (Debt), raising $29.4M.